(129 days)
Not Found
No
The summary describes a standard vital signs monitor with basic data display and storage features, and explicitly states "Not Found" for mentions of AI, DNN, or ML.
No
The device is a monitor used for diagnosis and does not provide therapy or treatment.
Yes
The device is described as monitoring and spot-checking blood pressure, oxygen saturation, and pulse, which are all physiological parameters used to assess a patient's health status and aid in diagnosis. It provides information on trends and previous readings, which are typically used for diagnostic purposes.
No
The device description explicitly mentions hardware components such as a monitor, accessories, a rugged carry bag, an internal rechargeable battery, an external battery charger, an LED display, and a pulse oximeter module.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The Oscillomate 9002 NIBP / Sp02 Monitor non-invasively measures blood pressure, oxygen saturation, and pulse directly from the patient's body using external sensors (like a blood pressure cuff and a pulse oximeter probe). It does not analyze samples taken from the body.
- Intended Use: The intended use describes monitoring physiological parameters of the patient, not analyzing biological samples.
Therefore, the device falls under the category of a patient monitor, which is a different type of medical device than an IVD.
N/A
Intended Use / Indications for Use
The Oscillomate 9002 NIBP / Sp02 Monitor Non-invasively measures blood pressure, oxygen saturation and the pulse of the adult and pediatric patient in EMS environments by health care professionals. It is not designed for continuous unsupervised monitoring.
Product codes
74DXN, 74DQA
Device Description
The 9002D Oscillomate NIBP / SP02 Monitor is a prescription device intended for use only by health care professionals.
The monitor is designed to monitor and spot check adult and pediatric patients for blood pressure, oxygen saturation, and pulse non-invasively in patient transport environments.
The monitor is portable, lightweight, and durable. The device and all of its accessories are further enclosed in a rugged Cordura nylon carry bag. Power is supplied by an internal rechargeable battery. An external battery charger is provided. Information is displayed in an easy to read LED display. NIBP Readings may be taken manually, or at preset intervals from 1 to 60 minutes. A message center display provides information and troubleshooting prompts. A history mode displays trends, previous readings and time readings were taken. Foreign language options and a data output port are included. The Sp02 function is derived from a pulse oximeter module mfg. by Nonin Medical, Inc.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Adult and pediatric patient
Intended User / Care Setting
Health care professionals; patient transport environments, EMS environments
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Nonclinical Tests:
Several bench tests were conducted to demonstrate safety and effectiveness of the Oscillomate 9002D and the monitoring parameters.
- Intra-device variability
- Combined device accuracy testing
- SP02 accuracy vs. simulation
- Environmental testing
- Electromagnetic Compatibility
- Safety Medical and Dental Equipment
- Safety Medical Electrical Equipment
Clinical Tests:
- The Oscillomate 9002D meets the clinical performance criteria of AAMI/ANSI SP10: 1992.
- The Nonin® Pulse Oximeter component has passed Sp02 clinical accuracy testing.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.2700 Oximeter.
(a)
Identification. An oximeter is a device used to transmit radiation at a known wavelength(s) through blood and to measure the blood oxygen saturation based on the amount of reflected or scattered radiation. It may be used alone or in conjunction with a fiberoptic oximeter catheter.(b)
Classification. Class II (performance standards).
0
The 1 6 1888
510(K) SUMMARY
Date prepared:
April 21, 1998
Contact:
CAS Medical Systems, Inc. 21 Business Park DR. Branford CT. 06405 (203) 488-6056 Fax (203) 488-9438
Contact person:
Ron Jeffrey Quality & Regulatory Affairs Manager
Trade name:
ﺮ
Common names:
Oscillomate® 9002D EMS NIBP/Sp02 Monitor
Physiological or Vital Signs Patient Monitor.
Includes the following parameters:
- Non-invasive Blood Pressure with . Pulse rate
- Pulse Oximeter & Heart Rate .
1
Classification
| Classification Name | 21 CFR Section | Product Code | Class |
|---|---|---|---|
| Monitor, Physiological, Patient | 2 | ||
| Non-invasive Blood Pressure | |||
| Measurement System | 870.1130 | 74DXN | 2 |
| Oximeter | 870.2700 | 74DQA | 2 |
Predicate Devices
CAS is claiming substantial equivalence to the following legally marketed device:
| Aspect | Device | 510(k) number |
|---|---|---|
| Monitor | Propaq 100 SERIES | |
| Multi-parameter Patient | ||
| Monitor | K910772 | |
| NIBP | Oscillomate 9001D NIBP | |
| by CAS Medical Systems | K972020 * | |
| Oximetry | Model 8500 by Nonin | |
| Medical, Inc. | K893221 |
- As of the date of this submission this device was pending 510k approval.
Device Description
The 9002D Oscillomate NIBP / SP02 Monitor is a prescription device intended for use only by health care professionals.
The monitor is designed to monitor and spot check adult and pediatric patients for blood pressure, oxygen saturation, and pulse non-invasively in patient transport environments.
The monitor is portable, lightweight, and durable. The device and all of its accessories are further enclosed in a rugged Cordura nylon carry bag. Power is supplied by an internal rechargeable battery. An external battery charger is provided. Information is displayed in an easy to read LED display. NIBP Readings may be taken manually, or at preset intervals from 1 to 60 minutes. A message center display provides information and troubleshooting prompts. A history mode displays trends, previous readings and time readings were taken. Foreign language options and a data output port are included. The Sp02 function is derived from a pulse oximeter module mfg. by Nonin Medical, Inc.
Intended Use
The Oscillomate 9002 NIBP / SP02 monitor non-invasively measures blood pressure, oxygen saturation, and the pulse of the adult and pediatric patient in
2
EMS environments by health care professionals. It is not designed for continuous unsupervised monitoring.
Comparison of Technological Characteristics
The CAS Oscillomate 9002D NIBP / SP02 monitor and its monitoring parameters have essentially the same technological characteristics as the Oscillomate 9001 predicate devices with regard to design, materials and energy source. There are no new technological characteristics. With regard to the Propaq 100 SERIES monitors there are minor differences. The differences are shown below.
- Some of the Propaq 100 series use Electroluminescent (EL) displays as an . option. The 9002D uses an LED display only
- The Propaq 100 series have an in-service mode that simulates patient data . for training. The 9002D does not have this mode.
- The 9002D monitor is designed to operate in a protective carry bag. Propaq . 100 series do not have a carry bag.
- The Propaq 100 series have alarms for set limits. The 9002D monitor does . not have patient alarms.
- The 9002D monitor has 4 patient controlled foreign language choices. This is . not available on the Propag 100 series monitors.
- The Propag 100 series with Sp02 have a tone pitch indicator which varies to . reflect changes in oxygen saturation. This feature is not present in the 9002D monitor.
All devices are microprocessor driven electronic devices using the Oscillometric technique for NIBP and the absorption of red and infrared light passing through tissue for the oxyhemoglobin saturation (%Sp02) values.
Nonclinical Tests
Several bench tests were conducted to demonstrate safety and effectiveness of the Oscillomate 9002D and the monitoring parameters.
- . Intra-device variability
- Combined device accuracy testing ●
- SP02 accuracy vs. simulation .
- Environmental testing .
- Electromagnetic Compatibility .
- Safety Medical and Dental Equipment .
- Safety Medical Electrical Equipment .
Clinical Tests
- The Oscillomate 9002D meets the clinical performance criteria of AAMI/ANSI . SP10: 1992.
- The Nonin® Pulse Oximeter component has passed Sp02 clinical accuracy . testing.
3
Conclusions
In accordance with 21 CFR part 807.92(b)(3) and as presented in this premarket notification, CAS Medical Systems, Inc. concludes that the new device, the Oscillomate 9002D NIBP / SP02 Monitor is safe and effective and substantially equivalent to the predicate devices as described.
Other Information
CAS Medical Systems, Inc. will update this summary with additional information if requested by the FDA.
4
Image /page/4/Picture/2 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" around the perimeter. Inside the circle is an abstract symbol resembling three stylized birds in flight, arranged in a stacked formation.
JUL 1 6 1998
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Mr. Ron Jeffrey CAS Medical Systems, Inc. Technology Applied to Medicine 21 Business Park Drive Branford, CT 06405
Re: K980879 OSCILLOMATE 9002 NIBP / Sp02 Monitor Regulatory Class: II (Two) Product Code: DQA Dated: June 23, 1998 Received: June 24, 1998
Dear Mr. Jeffrey:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General requlation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such Failure to comply with the GMP regulation may result in assumptions. requlatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
5
Page 2 - Mr. Ron Jeffrey
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the-Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html."
Sincerely yours,
Thomas J. Callahan
Thomas J. Callahan, Ph.D. Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
6
510(k) Number (if known):__
Image /page/6/Picture/1 description: The image shows a sequence of alphanumeric characters. The sequence starts with the letter 'K', followed by the numbers '980879'. The characters are written in a clear, legible font, and they appear to be underlined.
Device Name: _ OSCILLOMATE 9002 NIBP / Sp02 MONITOR
Indications For Usc:
The Oscillomate 9002 NIBP / Sp02 Monitor Non-invasively measures blood pressure, I no obemomation and the pulse of the adult and pediatric patient in EMS environments by health care professionals. It is not designed for continuous unsupervised monitoring.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Setre K. Kemperle
(Divisi
Division
and Neur:
510(k) Number K980879
Prescription Use / (Per 21 CFR 801.109) OR
Over-The-Counter Use
:
(Optional Format 1-2-96)